| Literature DB >> 35956821 |
Geir Bjørklund1, Md Shiblur Rahaman2,3, Mariia Shanaida4, Roman Lysiuk5,6, Petro Oliynyk7, Larysa Lenchyk8,9, Salvatore Chirumbolo10,11, Christos T Chasapis12, Massimiliano Peana13.
Abstract
Chronic exposure to arsenic (As) compounds leads to its accumulation in the body, with skin lesions and cancer being the most typical outcomes. Treating As-induced diseases continues to be challenging as there is no specific, safe, and efficacious therapeutic management. Therapeutic and preventive measures available to combat As toxicity refer to chelation therapy, antioxidant therapy, and the intake of natural dietary compounds. Although chelation therapy is the most commonly used method for detoxifying As, it has several side effects resulting in various toxicities such as hepatotoxicity, neurotoxicity, and other adverse consequences. Drugs of plant origin and natural dietary compounds show efficient and progressive relief from As-mediated toxicity without any particular side effects. These natural compounds have also been found to aid the elimination of As from the body and, therefore, can be more effective than conventional therapeutic agents in ameliorating As toxicity. This review provides an overview of the recently updated knowledge on treating As poisoning through natural dietary compounds. This updated information may serve as a basis for defining novel prophylactic and therapeutic formulations.Entities:
Keywords: arsenic; medicinal plants; natural compounds; toxicity; trace elements; vitamins
Mesh:
Substances:
Year: 2022 PMID: 35956821 PMCID: PMC9370003 DOI: 10.3390/molecules27154871
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1(a) Mechanism of Lewisite interaction (and similarly, monomethyl As(III) acid) with lipoic acid and the subsequent inhibition of PDH activity; (b) the antidote action of BAL and the restoring of PHD function.
Figure 2Scheme of C2H2, PHD, RING, and LIM zinc-finger domains.
Figure 3Chemical structures of the compounds active in alleviating arsenic toxicity.
Natural compounds active in alleviating arsenic toxicity.
| Common Name | IUPAC Name |
|---|---|
| Allicin | 3-prop-2-enylsulfinylsulfanylprop-1-ene |
| α-Lipoic acid | 5-(dithiolan-3-yl)pentanoic acid |
| α-Tocopherol | (2 |
| Arjunolic acid | (4a |
| Biochanin | 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one |
| β-Carotene | 1,3,3-trimethyl-2-[(1 |
| Curcumin | (1 |
| Diallyl sulfide | 3-prop-2-enylsulfanylprop-1-ene |
| D-pinitol | (1 |
| Ellagic acid | 6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione |
| Epigallocatechin-3-gallate | [(2 |
| Eriodictyol | (2 |
| Folic acid | (2 |
| Genistein | 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one |
| Hydroxytyrosol | 4-(2-hydroxyethyl)benzene-1,2-diol |
| Lutein | (1 |
| Melatonin | |
| Naringenin | 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one |
| Oleuropein | methyl (4 |
| Quercetin | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one |
| Resveratrol | 5-[( |
| Rutin | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2 |
| Sibilin | (2 |
| Sulforaphane | 1-isothiocyanato-4-methylsulfinylbutane |